Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Edelman

Showing results (281-290 of 348) with videos related to

Pageof 35
Sort By:
Critical Reviews in Oncology/Hematology|April 24, 2010
A retrospective analysis of outcomes by age in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel vs. paclitaxel plus carboplatin for advanced non-small cell lung cancerRafat H Ansari, Mark A Socinski, Martin J Edelman, et al.
Clinical Lung Cancer|November 11, 2009
Cooperative group research efforts in thoracic malignancies 2009: a review from the 10th Annual International Lung Cancer CongressHeather Wakelee, Bill W Loo, Kemp H Kernstine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Sequential Tracking of PD-L1 Expression and RAD50 Induction in Circulating Tumor and Stromal Cells of Lung Cancer Patients Undergoing RadiotherapyDaniel L Adams, Diane K Adams, Jianzhong He, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 7, 2023
"Cancer's a demon": a qualitative study of fear and multilevel factors contributing to cancer treatment delaysZachary A K Frosch, Lisa M Jacobs, Caroline S O'Brien, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 2, 2008
Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancerFrank C Detterbeck, Mark A Socinski, Richard J Gralla, et al.
Chest|February 4, 2009
Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancerM Patricia Rivera, Frank C Detterbeck, Mark A Socinski, et al.
Genes & Development|November 11, 2010
A genome-wide RNAi screen identifies multiple RSK-dependent regulators of cell migrationGromoslaw A Smolen, Jianmin Zhang, Matthew J Zubrowski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2009
A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancerJ A Treat, R Gonin, M A Socinski, et al.
JTO Clinical and Research Reports|December 2, 2024
S1701, A Randomized Phase 2 Trial of Carboplatin-Paclitaxel With and Without Ramucirumab in Patients With Locally Advanced, Recurrent, or Metastatic Thymic CarcinomaAnne S Tsao, Ming-Hui Hsieh, Marianna Koczywas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 1, 2011
Bortezomib for patients with advanced-stage bronchioloalveolar carcinoma: a California Cancer Consortium Phase II study (NCI 7003)Suresh S Ramalingam, Angela M Davies, Jeffrey Longmate, et al.
Pageof 35

Showing results (281-290 of 348) with videos related to

Sort By:
Pageof 35
Critical Reviews in Oncology/Hematology|April 24, 2010
A retrospective analysis of outcomes by age in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel vs. paclitaxel plus carboplatin for advanced non-small cell lung cancerRafat H Ansari, Mark A Socinski, Martin J Edelman, et al.
Clinical Lung Cancer|November 11, 2009
Cooperative group research efforts in thoracic malignancies 2009: a review from the 10th Annual International Lung Cancer CongressHeather Wakelee, Bill W Loo, Kemp H Kernstine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Sequential Tracking of PD-L1 Expression and RAD50 Induction in Circulating Tumor and Stromal Cells of Lung Cancer Patients Undergoing RadiotherapyDaniel L Adams, Diane K Adams, Jianzhong He, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 7, 2023
"Cancer's a demon": a qualitative study of fear and multilevel factors contributing to cancer treatment delaysZachary A K Frosch, Lisa M Jacobs, Caroline S O'Brien, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 2, 2008
Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancerFrank C Detterbeck, Mark A Socinski, Richard J Gralla, et al.
Chest|February 4, 2009
Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancerM Patricia Rivera, Frank C Detterbeck, Mark A Socinski, et al.
Genes & Development|November 11, 2010
A genome-wide RNAi screen identifies multiple RSK-dependent regulators of cell migrationGromoslaw A Smolen, Jianmin Zhang, Matthew J Zubrowski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2009
A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancerJ A Treat, R Gonin, M A Socinski, et al.
JTO Clinical and Research Reports|December 2, 2024
S1701, A Randomized Phase 2 Trial of Carboplatin-Paclitaxel With and Without Ramucirumab in Patients With Locally Advanced, Recurrent, or Metastatic Thymic CarcinomaAnne S Tsao, Ming-Hui Hsieh, Marianna Koczywas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 1, 2011
Bortezomib for patients with advanced-stage bronchioloalveolar carcinoma: a California Cancer Consortium Phase II study (NCI 7003)Suresh S Ramalingam, Angela M Davies, Jeffrey Longmate, et al.
Pageof 35